Objective: Herpes simplex virus infection through the neuronal route is the most well-studied mode of viral encephalitis that can persists in a human host for a lifetime. However, the involvement of other possible infection mechanisms by the virus remains underexplored. Therefore, this study aims to determine the temporal effects and mechanisms by which the virus breaches the human brain micro-vascular endothelial cells of the blood-brain barrier. Method: An electrical cell-substrate impedance-sensing tool was utilized to study the real-time cell-cell barrier or morphological changes in response to the virus infection. Results: Herpes simplex virus, regardless of type (i.e., 1 or 2), reduced the cell-cell barrier resistance almost immediately after virus addition to endothelial cells, with negligible involvement of cell-matrix adhesion changes. There is no exclusivity in the infection ability of endothelial cells. From 30 h after HSV infection, there was an increase in cell membrane capacitance with a subsequent loss of cell-matrix adhesion capability, indicating a viability loss of the infected endothelial cells. Conclusion: This study shows for the first time that destruction of human brain micro-vascular endothelial cells as an in vitro model of the blood-brain barrier could be an alternative invasion mechanism during herpes simplex virus infection.

1.
Granerod
J
,
Crowcroft
NS
.
The epidemiology of acute encephalitis
.
Neuropsychol Rehabil
.
2007
Aug-Oct
;
17
(
4-5
):
406
28
.
[PubMed]
0960-2011
2.
Spindler
KR
,
Hsu
TH
.
Viral disruption of the blood-brain barrier
.
Trends Microbiol
.
2012
Jun
;
20
(
6
):
282
90
.
[PubMed]
0966-842X
3.
Kanwar
JR
,
Sriramoju
B
,
Kanwar
RK
.
Neurological disorders and therapeutics targeted to surmount the blood-brain barrier
.
Int J Nanomedicine
.
2012
;
7
:
3259
78
.
[PubMed]
1176-9114
4.
Dolan
A
,
Jamieson
FE
,
Cunningham
C
,
Barnett
BC
,
McGeoch
DJ
.
The genome sequence of herpes simplex virus type 2
.
J Virol
.
1998
Mar
;
72
(
3
):
2010
21
.
[PubMed]
0022-538X
5.
Norberg
P
,
Kasubi
MJ
,
Haarr
L
,
Bergström
T
,
Liljeqvist
JA
.
Divergence and recombination of clinical herpes simplex virus type 2 isolates
.
J Virol
.
2007
Dec
;
81
(
23
):
13158
67
.
[PubMed]
0022-538X
6.
Rigamonti
A
,
Lauria
G
,
Mantero
V
,
Salmaggi
A
.
A case of late herpes simplex encephalitis relapse
.
J Clin Virol
.
2013
Sep
;
58
(
1
):
269
70
.
[PubMed]
1386-6532
7.
Koyuncu
OO
,
Hogue
IB
,
Enquist
LW
.
Virus infections in the nervous system
.
Cell Host Microbe
.
2013
Apr
;
13
(
4
):
379
93
.
[PubMed]
1931-3128
8.
van den Pol
AN
.
Viral infection leading to brain dysfunction: more prevalent than appreciated?
Neuron
.
2009
Oct
;
64
(
1
):
17
20
.
[PubMed]
0896-6273
9.
Stolwijk
JA
,
Matrougui
K
,
Renken
CW
,
Trebak
M
.
Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements
.
Pflugers Arch
.
2015
Oct
;
467
(
10
):
2193
218
.
[PubMed]
0031-6768
10.
Szulcek
R
,
Bogaard
HJ
,
van Nieuw Amerongen
GP
.
Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility
.
J Vis Exp
.
2014
Mar
;(
85
).
[PubMed]
1940-087X
11.
Man
S
,
Ubogu
EE
,
Williams
KA
,
Tucky
B
,
Callahan
MK
,
Ransohoff
RM
.
Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration
.
Clin Dev Immunol
.
2008
;
2008
:
384982
.
[PubMed]
1740-2522
12.
Yosef
N
,
Ubogu
EE
.
An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies
.
Cell Mol Neurobiol
.
2013
Mar
;
33
(
2
):
175
86
.
[PubMed]
0272-4340
13.
Tan
WC
,
Jaganath
IB
,
Manikam
R
,
Sekaran
SD
.
Evaluation of antiviral activities of four local Malaysian Phyllanthus species against herpes simplex viruses and possible antiviral target
.
Int J Med Sci
.
2013
Oct
;
10
(
13
):
1817
29
.
[PubMed]
1449-1907
14.
Blakeney
S
,
Kowalski
J
,
Tummolo
D
,
DeStefano
J
,
Cooper
D
,
Guo
M
, et al.
Herpes simplex virus type 2 UL24 gene is a virulence determinant in murine and guinea pig disease models
.
J Virol
.
2005
Aug
;
79
(
16
):
10498
506
.
[PubMed]
0022-538X
15.
Dedera
D
,
Ratner
L
.
Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants
.
J Virol
.
1991
Nov
;
65
(
11
):
6129
36
.
[PubMed]
0022-538X
16.
Wegener
J
,
Keese
CR
,
Giaever
I
.
Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces
.
Exp Cell Res
.
2000
Aug
;
259
(
1
):
158
66
.
[PubMed]
0014-4827
17.
Abbott
NJ
.
Blood-brain barrier structure and function and the challenges for CNS drug delivery
.
J Inherit Metab Dis
.
2013
May
;
36
(
3
):
437
49
.
[PubMed]
0141-8955
18.
Berger
JR
,
Houff
S
.
Neurological complications of herpes simplex virus type 2 infection
.
Arch Neurol
.
2008
May
;
65
(
5
):
596
600
.
[PubMed]
0003-9942
19.
Cunningham
AL
,
Diefenbach
RJ
,
Miranda-Saksena
M
,
Bosnjak
L
,
Kim
M
,
Jones
C
, et al.
The cycle of human herpes simplex virus infection: virus transport and immune control
.
J Infect Dis
.
2006
Sep
;
194
(
s1
Suppl 1
):
S11
8
.
[PubMed]
0022-1899
20.
Jacobs
A
,
Breakefield
XO
,
Fraefel
C
.
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis
.
Neoplasia
.
1999
Nov
;
1
(
5
):
387
401
.
[PubMed]
1522-8002
21.
Sellner
J
,
Simon
F
,
Meyding-Lamade
U
,
Leib
SL
.
Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation
.
Brain Res
.
2006
Dec
;
1125
(
1
):
155
62
.
[PubMed]
0006-8993
22.
Melchjorsen
J
,
Sirén
J
,
Julkunen
I
,
Paludan
SR
,
Matikainen
S
.
Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3
.
J Gen Virol
.
2006
May
;
87
(
Pt 5
):
1099
108
.
[PubMed]
0022-1317
23.
Durmanová
V
,
Sapák
M
,
Kosovský
J
,
Rezuchová
I
,
Kúdelová
M
,
Buc
M
, et al.
Immune response and cytokine production following immunization with experimental herpes simplex virus 1 (HSV-1) vaccines
.
Folia Microbiol (Praha)
.
2008
;
53
(
1
):
73
83
.
[PubMed]
0015-5632
24.
Schachtele
SJ
,
Hu
S
,
Little
MR
,
Lokensgard
JR
.
Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2
.
J Neuroinflammation
.
2010
Jun
;
7
(
1
):
35
.
[PubMed]
1742-2094
25.
Kavouras
JH
,
Prandovszky
E
,
Valyi-Nagy
K
,
Kovacs
SK
,
Tiwari
V
,
Kovacs
M
, et al.
Herpes simplex virus type 1 infection induces oxidative stress and the release of bioactive lipid peroxidation by-products in mouse P19N neural cell cultures
.
J Neurovirol
.
2007
Oct
;
13
(
5
):
416
25
.
[PubMed]
1355-0284
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.